trial of ibrutinib with bendamustine and rituximab in cll: results and study design
Published 8 years ago • 124 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
1:46
philemon trial: ibrutinib, lenalidomide and rituximab in r/r mcl
-
1:43
eradic trial: preliminary results of mrd-guided ibrutinib plus venetoclax vs fcr
-
2:52
updated analysis of phase iii trial of idelalisib combined with bendamustine and rituximab in cll
-
1:36
cll2-give trial: ibrutinib, venetoclax and obinutuzumab in patients with tp53-mutated cll
-
1:30
bendamustine-rituximab vs ibrutinib as frontline therapy in waldenström's macroglobulinemia
-
1:01
pirtobrutinib, venetoclax, and rituximab in the treatment of r/r cll: insights from the bruin trial
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
3:00
five-year follow-up of the captivate trial: ibrutinib retreatment in patients with cll
-
4:15
zanubrutinib versus rituximab-based chemoimmunotherapy in waldenström's macroglobulinemia
-
4:22
discover versiti diagnostic labs, clinical trials and biomaterials | versiti
-
1:46
continuous improvement for 1 year after perispinal etanercept treatment by edward tobinick, m.d.
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
5:29
helios trial: ibrutinib combined with br for previously treated cll/sll
-
4:33
brawm: bendamustine, rituximab and acalabrutinib for waldenström’s macroglobulinemia
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:55
the alpine trial shows improved outcomes with zanubrutinib versus ibrutinib in r/r cll
-
3:28
the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
-
1:37
causes & management of ibrutinib discontinuation in cll
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:35
pirtobrutinib in r/r fl: results from the bruin study